CClinicalTrials.gg
CompletedNCT01661478Updated Jan 18, 2017

Healthcare Provider Attitudes Towards Patients With Substance Use Before and After Implementation of the SBIRT Model in the Emergency Room

An observational study in Patients With Substance Abuse and Healthcare Provider Attitudes, sponsored by University of Alabama at Birmingham. Completed at 2 sites in United States. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2017-01-18.

Sponsored by University of Alabama at Birmingham · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
200
Ages
19 Years and older
Sex
All
01

Study summary

The purpose of this quality improvement research project is to briefly survey attitudes among healthcare providers toward patients with substance use disorders before and after substance abuse counselors are placed in the Emergency Room.

Read the detailed description

The purpose of this quality improvement research project is to briefly survey attitudes among healthcare providers toward patients with substance use disorders before and after substance abuse counselors are placed in the Emergency Room. SBIRT stands for Screening Brief Intervention and Referral to Treatment. The pre-test survey contains 10 questions about attitudes toward patients with substance use disorders and the post-test survey consists of 13 questions about attitudes toward patients with substance use disorders and questions regarding the SBIRT model itself. Health care providers will be surveyed before the SBIRT Counselors begin and again at 6 months, after full SBIRT program with substance counselors on site has been in place, as a part of their regular staff education requirements. Part of the goal of the SBIRT counselors is to educate providers about treatment and analyze data collected by and comments of Emergency Room staff.

02

Conditions studied

  • Patients With Substance Abuse
  • Healthcare Provider Attitudes
03

In context

Emergencies

1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.

This study's enrollment of 200 is below the median of 353 across 714 observational studies indexed under Emergencies.

Browse Emergencies studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,397 studies on the registry; 285 are open to participants now.

Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Personnel in the Emergency Medicine Department and the Department of Psychiatry

Inclusion criteria

  • UAB Emergency Department Staff (attending, resident, nurse, social worker, case manager, patient care technician) or Psychiatry Emergency Services staff (nurses, social workers and residents)

Exclusion criteria

Exclusion Criteria:

  • Not employed in UAB Emergency Department
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
200 participants (actual)

Groups and cohorts

  • Emergency Department personnel

    survey

    Other: Training on motivational interviewing

  • Department of Psychiatry personnel

    survey

    Other: Training on motivational interviewing

Interventions

  • OtherTraining on motivational interviewing
06

Study locations

2 sites
  • University of Alabama at Birmingham
    Birmingham, Alabama 35205, United States
  • University of Alabama Birmingham
    Birmingham, Alabama 35205, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 18, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01661478
Lead sponsor
University of Alabama at Birmingham
Responsible party
Cheryl McCullumsmith (Division Director, Hospital Psychiatry, University of Alabama at Birmingham) — Principal investigator
First posted
Aug 9, 2012
Start date
Sep 2011
Last update
Jan 18, 2017
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion